New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

Aug 05, 2022
The Government regrets that the UK’s association to Horizon Europe has not yet been formalised as a result of disagreements related to the NI Protocol and recognises the huge toll that this has placed on the UK’s research and business community. To mitigate the impact of the uncertainty, the Government developed the Horizon Europe guarantee in November 2021 – which ensures funding to researchers and innovators unable to receive their Horizon Europe funding while the U...
Read More
Aug 05, 2022
A new report from the House of Lords Science and Technology Committee, entitled “Science and technology superpower”: more than a slogan?, has called for the Government to provide more clarity regarding their science and technology implementation plans. The Committee has welcomed the Government’s stated ambitions but warns that without concrete detail their slogans risk becoming empty in meaning.Among the science and technology commitments which have been welcomed are: the aim t...
Read More
Aug 05, 2022
NHS England patients with Type 1 diabetes will now be eligible for life-changing continuous glucose monitors after the health service secured a new cut-price deal. The wearable arm gadget sends information to a mobile app and allows diabetes patients to monitor their glucose levels at any time without having to scan or take a finger prick test.Normally continuous glucose monitors are more expensive than flash monitors – which record glucose levels by scanning a sensor – but due to th...
Read More
Jul 29, 2022
NICE have released new guidance which recommends the routine use of placental growth factor-based tests (PLGF) to better diagnose pre-eclampsia. This move could lead to better outcomes for thousands of babies and their mothers in the future. Pre-eclampsia affects one out of 10 pregnancies and often leads to serious complications if left untreated.
Read More
Jul 29, 2022
Despite making up more than half of the UK population, women are much more likely to suffer ill health and disability throughout their lives. Therefore, a strategy targeted specifically at women’s health, and how to alleviate the problems outlined, is vital.
Read More
Jul 29, 2022
Bruce Daniel, Head of Pathology for NHS England, South West region, explains what a day in his working life is like.
Read More
Jul 29, 2022
A collaboration between the North East Innovation Lab and the National Institute for Health and Care Research (NIHR) Newcastle In Vitro Diagnostics Co-operative has secured joint funding of around £20,000.
Read More
Jul 18, 2022
New Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.
Read More
Jul 18, 2022
As BIVDA attended the APPG for Life Sciences event based on the new ‘Data Saves Lives’ Strategy this week, we have provided some information on the action plan for members.The Strategy aims to reshape health and social care through more effective use of data, increased trust from the public in health data provision, leveraging technologies to allow better access to care records for patients and ultimately, swifter treatment and improved patient outcomes.Some of the key tenets of the ...
Read More
Jul 18, 2022
The Crown Commercial Service (CCS), the UK’s largest public procurement organisation, is working in partnership with NHS England and the Department of Health and Social Care (DHSC) to provide Atamis software licences to support health sector buyers, procurement teams, data analysts, and commercial teams to adopt the e-commerce system.Following the launch of the NHS Central Commercial Function (CCF), at Public Board on 7th July, the rollout of Atamis will provide greater insight into procur...
Read More
Page 5 of 34 [5]

Interested in becoming a member? Join us!

Copyright 2023 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858